López-Caballero F, Coffman B A, Curtis M, Sklar A L, Yi S, Salisbury D F
Clinical Neurophysiology Research Laboratory, Western Psychiatric Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Clinical Neurophysiology Research Laboratory, Western Psychiatric Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA, USA.
Neuroimage Clin. 2025;45:103730. doi: 10.1016/j.nicl.2024.103730. Epub 2025 Jan 2.
Predicting symptom progression in first-episode psychosis (FEP) is crucial for tailoring treatment and improving outcomes. Temporal lobe function, indicated by neurophysiological biomarkers like N100, predicts symptom progression and correlates with untreated psychosis. Our recent report showed that source-localized magnetoencephalography (MEG) M100 responses to tones in an oddball paradigm predicted recovery in FEP positive symptoms. This study expands these results with a simpler single-tone paradigm, with both MEG and EEG, and measuring associations across symptom dimensions. We recorded MEG (M100) and EEG (N100) in 29 FEP individuals and assessed symptom severity at baseline and after ∼ 7 months using the Positive and Negative Syndrome Scale (PANSS). Sequential regression analyses predicted symptom change (ΔPANSS) from Duration of untreated Active Psychosis (DAP) and baseline M100, controlling for baseline symptoms. Identical regressions were conducted in a subsample measuring N100 with EEG (n = 24). Smaller baseline M100 predicted worse symptom recovery at follow-up, independent of baseline symptom severity. Longer DAP showed a similar predictive effect, but this relationship was accounted for by M100. Regressions revealed M100 predictions were mostly related to general psychopathology. Identical results were found for N100 measured with EEG. Temporal lobe dysfunction in FEP, especially poor auditory sensory processing, indicates a worse recovery trajectory in general psychopathology. Longer untreated psychosis worsens temporal lobe function, predicting poorer progression. N100 measured with EEG and a single-tone task could be a cost-effective tool for informing clinicians about overall symptom progression, guiding treatment resource allocation and interventions.
预测首发精神病(FEP)的症状进展对于定制治疗方案和改善治疗结果至关重要。由N100等神经生理学生物标志物所表明的颞叶功能可预测症状进展,并与未治疗的精神病相关。我们最近的报告显示,在一个oddball范式中,源定位脑磁图(MEG)对音调的M100反应可预测FEP阳性症状的恢复情况。本研究采用更简单的单音范式,同时使用MEG和脑电图(EEG),并测量不同症状维度之间的关联,从而扩展了这些结果。我们记录了29名FEP患者的MEG(M100)和EEG(N100),并使用阳性和阴性症状量表(PANSS)在基线和大约7个月后评估症状严重程度。顺序回归分析从未治疗的活动性精神病持续时间(DAP)和基线M100预测症状变化(ΔPANSS),同时控制基线症状。在一个使用EEG测量N100的子样本(n = 24)中进行了相同的回归分析。较小的基线M100预测随访时症状恢复较差,且与基线症状严重程度无关。较长的DAP显示出类似的预测效果,但这种关系可由M100解释。回归分析显示M100的预测大多与一般精神病理学相关。用EEG测量N100时也得到了相同的结果。FEP中的颞叶功能障碍,尤其是听觉感觉处理能力差,表明在一般精神病理学方面恢复轨迹较差。未治疗的精神病持续时间越长,颞叶功能越差,预示着病情进展越差。用EEG测量的N100和单音任务可能是一种经济有效的工具,可让临床医生了解整体症状进展情况,指导治疗资源分配和干预措施。